OTC Markets EXMKT - Delayed Quote USD

Levitee Labs Inc. (LVTTF)

Compare
0.0027 0.0000 (0.00%)
At close: November 18 at 3:00:00 PM EST
Loading Chart for LVTTF
DELL
  • Previous Close 0.0000
  • Open 0.0000
  • Bid --
  • Ask --
  • Day's Range 0.0000 - 0.0000
  • 52 Week Range 0.0000 - 0.0027
  • Volume 500
  • Avg. Volume 0
  • Market Cap (intraday) 369,154
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) --
  • EPS (TTM) -0.1100
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Levitee Labs Inc., a multidisciplinary integrative wellness company, provides evidence-based alternative medicines and novel psychedelic therapies. The company operates through two segments, Medical Services and Selling Products. It offers treatments and medications for substance use disorders and chronic pain, such as myofascial pain, fibromyalgia, neuropathy, and chronic regional pain syndrome, as well as hepatitis-C and mental health conditions. The company operates five clinics under the Levitee Clinics name; and three pharmacies in Alberta under the Levitee Pharmacies name. In addition, it offers electronic-prescriptions in the addiction treatment space under the BlockMD name; and wholesales supplements and superfood under the Earth Circle Organics name. The company was formerly known as Fibonacci Capital Corp. and changed its name to Levitee Labs Inc. in November 30, 2020. Levitee Labs Inc. was incorporated in 2019 and is based in Vancouver, Canada.

www.leviteelabs.com

--

Full Time Employees

--

Fiscal Year Ends

Recent News: LVTTF

View More

Performance Overview: LVTTF

Trailing total returns as of 12/20/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

LVTTF
0.00%
S&P/TSX Composite index
17.37%

1-Year Return

LVTTF
0.00%
S&P/TSX Composite index
18.04%

3-Year Return

LVTTF
98.90%
S&P/TSX Composite index
18.61%

5-Year Return

LVTTF
99.24%
S&P/TSX Composite index
44.16%

Compare To: LVTTF

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: LVTTF

View More

Valuation Measures

Annual
As of
  • Market Cap

    --

  • Enterprise Value

    --

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    --

  • Diluted EPS (ttm)

    -0.1100

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    --

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: LVTTF

View More

Company Insights: LVTTF

Research Reports: LVTTF

View More

People Also Watch